Transplant Psychosocial Evaluation Report (SIPAT-Informed)

Report Title: Transplant Psychosocial Evaluation Report (SIPAT-Informed)

Patient: [Patient full name], MRN: [MRN], DOB/Age: [DOB / age]

Evaluation Date/Time: [Date and time]

Location: [inpatient / outpatient / telehealth]

Evaluator(s): [Name(s), discipline, credentials]

Referring Service: [Referring service or provider name]

Organ(s) Under Evaluation: [Organ(s)]

Transplant Stage: [pre-listing evaluation / re-evaluation / waitlist update / urgent bedside]

(Documentation guidance: Use behaviorally specific, time-anchored descriptions rather than global labels; distinguish barriers from motivation; focus on feasibility of meeting post-transplant tasks even when supports are non-traditional; when information is missing, document "unable to assess" with reason and note impact on conclusions.)

Referral Question and Transplant Context

[Reason for referral and specific transplant team questions] (State the primary referral questions such as adherence risk, substance use risk, caregiver feasibility, or psychiatric stability. Note any medical urgency constraints influencing evaluation scope and any prior transplant history or psychosocial concerns from past listing decisions. If no specific question was provided, state that evaluation was conducted per standard transplant psychosocial domains.)

Sources of Information and Reliability

• [Interview participants] (Patient, caregivers, and other collaterals with names/relationships.)
• [Records reviewed] (EHR notes, outside records, dialysis logs, pharmacy refill history, toxicology/biomarkers, PDMP.)
• [Interpreter used] (Language and modality; omit if not applicable.)
• [Standardized tools administered] (Name and date; omit if none.)

Reliability: [Reliability statement] (State confidence level and limitations such as medical instability, encephalopathy, guardedness, inconsistent reporting, cognitive impairment, time constraints, or inability to reach collateral.)

Psychosocially-Relevant Medical Snapshot

• [Primary diagnosis and current functional status]
• [Neurocognitive risk factors] (E.g., encephalopathy, hypoxia, prior stroke; omit if none.)
• [Current treatment complexity] (E.g., dialysis schedule, device management, transplant education status.)
• [Documented adherence markers] (E.g., missed treatments/visits, refill gaps; present factually with dates.)

Psychosocial Evaluation Findings

Readiness, Illness Understanding, and Adherence

[Summary of understanding, readiness, and adherence] (Synthesize the patient's understanding of illness trajectory, transplant rationale, and post-transplant demands. Describe readiness and motivation. Distinguish barriers from motivational factors. If unable to assess, state reason and impact on conclusions.)

• [Understanding of condition and transplant rationale]
• [Understanding of post-transplant requirements] (Medications, labs, clinic visits, infection precautions.)
• [Prior adherence behaviors] (Appointment attendance, dialysis attendance, medication-taking—with corroboration where available.)
• [Identified barriers to adherence] (Transportation, housing, cost/insurance, cognitive issues, literacy, language; specify frequency and impact.)
• [Self-management skills] (Medication organization, reminder use, healthcare navigation ability.)
• [Motivation and stated goals]
• [Contingency plans if primary support becomes unavailable]

Social Support and Caregiving Plan

[Summary of caregiving feasibility] (Identify primary caregiver, availability, reliability, and understanding of demands. Include backup supports and community resources. Emphasize feasibility of meeting post-transplant tasks; non-traditional supports are acceptable if tasks are covered. If unable to assess, state reason and impact.)

• [Primary caregiver] (Name/relationship, proximity, availability, reliability.)
• [Caregiver interview summary] (Understanding of responsibilities, transportation capability, medication support.)
• [Backup supports and community resources]
• [Living situation] (Stability, safety, space for recovery.)
• [Transportation plan] (Distance to center, routine transport, backup options.)
• [Financial/insurance feasibility] (Note barriers and mitigation steps.)
• Feasibility statement: [Support plan feasibility and any conditions] (E.g., contingent upon completion of transplant education and confirmed caregiver availability.)

Psychological Stability and Psychopathology

[Summary of psychiatric history and current stability] (Outline diagnoses, treatments, responses, and current symptoms with functional impact. Provide a brief mental status examination. If any safety risk indicator exists, include safety assessment and plan. Note reporting inconsistencies with specific examples. If unable to assess, state reason and impact.)

• [Psychiatric history] (Diagnoses, hospitalizations, treatments, adherence.)
• [Current symptoms and functional impact] (Depression, anxiety, psychosis, mania, trauma symptoms.)
• [Mental status examination] (Appearance/behavior; speech; mood/affect; thought process/content; perception; cognition grossly; insight/judgment.)
• [Safety assessment] (Suicidal ideation, self-harm, violence risk, protective factors, safety plan; include only if indicated.)
• [Personality/coping factors relevant to adherence or support stability] (Omit if not relevant.)

Lifestyle and Substance Use

[Summary of substance use risk and monitoring] (For each applicable substance class, document history, most recent use, consequences, treatments, and relapse patterns. Separate objective data from self-report. State monitoring status and readiness. If abstinence duration is uncertain, state explicitly and recommend confirmatory testing. If unable to assess, state reason and impact.)

• Alcohol: [Use history and timeline; most recent use date; consequences; prior treatment and response; relapse history/triggers; current monitoring and readiness.]
• Tobacco/Nicotine: [Use pattern; quit attempts; pharmacotherapy; current status.]
• Cannabis: [Use pattern; frequency; route; monitoring.]
• Illicit drugs: [Substance(s), history, most recent use, consequences, treatments, monitoring.]
• Prescribed controlled substances: [Indication, dosing oversight, PDMP review, aberrant behaviors if any.]
• Objective data: [Toxicology/biomarkers with dates and results; distinguish from self-report.]

Cognitive Status and Decision-Making Capacity

[Cognitive status and capacity evaluation] (Summarize evidence of cognitive impairment from chart and bedside observation. Assess capacity elements: understanding, appreciation, reasoning, ability to communicate choice. Provide clear conclusion. If uncertain, recommend next steps such as neuropsychological testing or reassessment when medically optimized. If not assessable, document why and note collateral impressions.)

Additional Psychosocial Factors

[Other relevant factors] (Include as applicable: current stressors, coping strengths, education and health literacy, employment/scheduling constraints, language needs and communication preferences, cultural/spiritual factors influencing decision-making, and pertinent legal considerations such as guardianship or active legal issues impacting care access. Omit section if no additional factors are relevant.)

SIPAT Scoring (Optional)

[SIPAT total score and interpretive category; domain scores for Readiness, Social Support, Psychopathology, and Lifestyle/Substance Use; note any red-flag items] (If SIPAT was not performed, write: "SIPAT scoring not completed; narrative domains assessed.")

SIPAT is used to supplement—not replace—clinical judgment and multidisciplinary selection processes.

Psychosocial Risk Formulation and Candidacy Statement

Key Strengths:

• [Protective factor] (E.g., consistent attendance, stable caregiver with confirmed availability, sustained psychiatric stability with treatment adherence, active engagement in recovery supports.)
• [Protective factor]
• [Protective factor]

Key Risks and Concerns:

• [Domain]: [Risk statement with specific evidence] — [modifiable / partially modifiable / non-modifiable]
• [Domain]: [Risk statement with specific evidence] — [modifiable / partially modifiable / non-modifiable]
• [Domain]: [Risk statement with specific evidence] — [modifiable / partially modifiable / non-modifiable]

Candidacy Recommendation:

Psychosocial Risk Level: [Low / Moderate / High]

Readiness Status: [Ready now / Ready with conditions / Defer pending mitigation / Unable to determine due to insufficient data]

[Rationale] (Provide 2–4 sentence rationale linking to key strengths and risks. Note time sensitivity and specify which mitigations can occur post-listing versus must occur pre-listing. Avoid absolute language such as "not a candidate" unless program policy requires; instead describe current contraindications and necessary mitigations.)

Targeted Recommendations and Mitigation Plan

(List actions prioritized by impact and feasibility. Categories to address as applicable: adherence readiness and education; caregiver plan and backup confirmation; mental health stabilization; substance use risk mitigation and monitoring; cognitive/capacity evaluation and surrogate identification; social determinants supports.)

• Recommendation 1: [Action item]

  • Rationale: [Link to identified risk]
  • Responsible: [Patient / Caregiver / Transplant coordinator / Social work / Psychiatry / Addiction medicine / Other]
  • Timing: [pre-listing / pre-transplant / post-transplant]
  • Success metric: [How completion will be verified]

• Recommendation 2: [Action item]

  • Rationale: [Link to identified risk]
  • Responsible: [Patient / Caregiver / Team role]
  • Timing: [pre-listing / pre-transplant / post-transplant]
  • Success metric: [How completion will be verified]

Follow-Up Plan and Re-Evaluation Triggers

• Re-evaluation timing: [Time frame tied to mitigation milestones]
• Early reassessment triggers: [Relapse / psychiatric hospitalization / caregiver change / missed treatments / new safety concerns]
• Communication to committee: [Who will report progress and where documented]

Closing

Evaluator Signature: [Name]

Credentials: [Credentials and discipline]

Date: [Date of finalization]

Distribution: Shared with transplant selection committee via EHR.